Efficacy of venetoclax as targeted therapy for relapsed/refractory t(11;14) multiple myeloma

Shaji Kumar*, Jonathan L. Kaufman, Cristina Gasparetto, Joseph Mikhael, Ravi Vij, Brigitte Pegourie, Lofti Benboubker, Thierry Facon, Martine Amiot, Philippe Moreau, Elizabeth A. Punnoose, Stefanie Alzate, Martin Dunbar, Tu Xu, Suresh K. Agarwal, Sari Heitner Enschede, Joel D. Leverson, Jeremy A. Ross, Paulo C. Maciag, Maria VerdugoCyrille Touzeau

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

360 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy of venetoclax as targeted therapy for relapsed/refractory t(11;14) multiple myeloma'. Together they form a unique fingerprint.

Chemistry

Medicine & Life Sciences